This year, a joint BTS-UKEMS Congress will be held at Robinson College, Cambridge, from 15th – 17th April 2019.
IGG will host a session on Monday 15th April:
Symposium 4: New paradigms of genotoxicity safety evaluation for risk assessment
Chairs: Dr Julia Kenny (GSK) & Dr Patricia Parris (AstraZeneca)
16:45 – 17:15 Bob Young (Merck, Bioreliance Testing Services)
Use of Duplex Sequencing™ for Detection of In Vivo Mutagenesis and early Preneoplastic Events as Biomarkers of Human Cancer Risk (sponsored by Merck)
17:15 – 17:45 Dr Stefan Pfuhler (P&G)
Newly Validated 3D Skin Genotoxicity Assays Improve Safety Assessments of Cosmetic Ingredients
17:45 – 18:15 Dr Giel Hendriks (Toxys)
Novel extensions of the ToxTracker genotoxicity assay to provide insight into mode of action of aneugenic and clastogenic chemicals
18:15 – 18:30 Ms Rebekah Beck (University of Manchester)
Genome-wide and gene-specific methylation assays to identify potential associations between de-methylating compounds and genotoxicity.
Download the Meeting Flyer here.